Search Results - "Postmus, P."

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Postmus, P.E., Kerr, K.M., Oudkerk, M., Senan, S., Waller, D.A., Vansteenkiste, J., Escriu, C., Peters, S.

Get full text

Iron deficiency is common in idiopathic pulmonary arterial hypertension by RUITER, G, LANKHORST, S, BOONSTRA, A, POSTMUS, P. E, ZWEEGMAN, S, WESTERHOF, N, VAN DER LAARSE, W. J, VONK-NOORDEGRAAF, A

“…The aims of this study were to assess the prevalence of iron deficiency in idiopathic pulmonary arterial hypertension (IPAH) and investigate whether oral iron…”
Get full text

Incidence of T790M mutation in (sequential) rebiopsies in EGFR -mutated NSCLC-patients by Kuiper, J.L, Heideman, D.A.M, Thunnissen, E, Paul, M.A, van Wijk, A.W, Postmus, P.E, Smit, E.F

“…Abstract Aim Non-small cell lung cancer (NSCLC)-patients with an epidermal growth factor receptor ( EGFR )-mutation have median progression-free survival (PFS)…”
Get full text

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy by Overbeek, M. J, Vonk, M. C, Boonstra, A, Voskuyl, A. E, Vonk-Noordegraaf, A, Smit, E. F, Dijkmans, B. A. C, Postmus, P. E, Mooi, W. J, Heijdra, Y, Grunberg, K

“…Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a worse prognosis and response to pulmonary arterial hypertension (PAH) therapy than…”
Get full text

Effects of exercise training in patients with idiopathic pulmonary arterial hypertension by de Man, F. S, Handoko, M. L, Groepenhoff, H, van 't Hul, A. J, Abbink, J, Koppers, R. J. H, Grotjohan, H. P, Twisk, J. W. R, Bogaard, H-J, Boonstra, A, Postmus, P. E, Westerhof, N, van der Laarse, W. J, Vonk-Noordegraaf, A

“…We determined the physiological effects of exercise training on exercise capacity and quadriceps muscle function in patients with idiopathic pulmonary arterial…”
Get full text

The arterial load in pulmonary hypertension by Saouti, N, Westerhof, N, Postmus, P E, Vonk-Noordegraaf, A

“…The anatomical differences between the pulmonary and systemic arterial system are the main cause of the difference in distribution of compliance. In the…”
Get full text

Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension by HANDOKO, M. L, DE MAN, F. S, HAPPE, C. M, SCHALIJ, I, MUSTERS, R. J. P, WESTERHOF, N, POSTMUS, P. E, PAULUS, W. J, VAN DER LAARSE, W. J, VONK-NOORDEGRAAF, A

“…Exercise training in pulmonary arterial hypertension (PH) is a promising adjunct to medical treatment. However, it is still unclear whether training is…”
Get full text

Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment by Kuiper, J L, Hashemi, S M S, Thunnissen, E, Snijders, P J F, Grünberg, K, Bloemena, E, Sie, D, Postmus, P E, Heideman, D A M, Smit, E F

“…Background: Data on non-small-cell lung cancer (NSCLC) patients with non-classic epidermal growth factor receptor ( EGFR ) mutations are scarce, especially in…”
Get full text

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment by Becker, A, Crombag, L, Heideman, D.A.M, Thunnissen, F.B, van Wijk, A.W, Postmus, P.E, Smit, E.F

“…Abstract Background Tyrosine kinase inhibitors (TKI) of the epidermal growth factor receptor (EGFR) are approved as treatment of non-small-cell lung cancer…”
Get full text

Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis by Hofstee, H M A, Vonk Noordegraaf, A, Voskuyl, A E, Dijkmans, B A C, Postmus, P E, Smulders, Y M, Serné, E H

“…The aim of this study was to investigate whether there are differences in capillary nailfold changes in patients with systemic sclerosis (SSc) with and without…”
Get more information

Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families by Houweling, A C, Gijezen, L M, Jonker, M A, van Doorn, M B A, Oldenburg, R A, van Spaendonck-Zwarts, K Y, Leter, E M, van Os, T A, van Grieken, N C T, Jaspars, E H, de Jong, M M, Bongers, E M H F, Johannesma, P C, Postmus, P E, van Moorselaar, R J A, van Waesberghe, J-Htm, Starink, T M, van Steensel, M A M, Gille, J J P, Menko, F H

“…Background: Birt–Hogg–Dubé (BHD) syndrome is an autosomal dominant condition caused by germline FLCN mutations, and characterised by fibrofolliculomas,…”
Get full text

Sildenafil treatment in COPD does not affect stroke volume or exercise capacity by Rietema, H, Holverda, S, Bogaard, H. J, Marcus, J. T, Smit, H. J, Westerhof, N, Postmus, P. E, Boonstra, A, Vonk-Noordegraaf, A

“…In chronic obstructive pulmonary disease (COPD) patients, stroke volume response to exercise is impaired. The aim of the present study was to investigate…”
Get full text

RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension by Saouti, N, Westerhof, N, Helderman, F, Marcus, J T, Stergiopulos, N, Westerhof, B E, Boonstra, A, Postmus, P E, Vonk-Noordegraaf, A

“…The product of resistance, R, and compliance, C (RC time), of the entire pulmonary circulation is constant. It is unknown if this constancy holds for…”
Get more information

Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil by MOUCHAERS, K. T. B, SCHALIJ, I, DE BOER, M. A, POSTMUS, P. E, VAN HINSBERGH, V. W. M, VAN NIEUW AMERONGEN, G. P, VONK NOORDEGRAAF, A, VAN DER LAARSE, W. J

“…Pulmonary arterial hypertension (PAH) still cannot be cured, warranting the search for novel treatments. Fasudil (a Rho kinase inhibitor) was compared with…”
Get full text

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach by Hubers, A J, Heideman, D A M, Burgers, S A, Herder, G J M, Sterk, P J, Rhodius, R J, Smit, H J, Krouwels, F, Welling, A, Witte, B I, Duin, S, Koning, R, Comans, E F I, Steenbergen, R D M, Postmus, P E, Meijer, G A, Snijders, P J F, Smit, E F, Thunnissen, E

“…Background: Lung cancer has the highest mortality of all cancers. The aim of this study was to examine DNA hypermethylation in sputum and validate its…”
Get full text

Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach by de Graaf, M.A., Antoni, M.L., ter Kuile, M.M., Arbous, M.S., Duinisveld, A.J.F., Feltkamp, M.C.W., Groeneveld, G.H., Hinnen, S.C.H., Janssen, V.R., Lijfering, W.M., Omara, S., Postmus, P.E., Ramai, S.R.S., Rius-Ottenheim, N., Schalij, M.J., Schiemanck, S.K., Smid, L., Stöger, J.L., Visser, L.G., de Vries, J.J.C., Wijngaarden, M.A., Geelhoed, J.J.M., Roukens, A.H.E.

“…Short-term follow-up of COVID-19 patients reveals pulmonary dysfunction, myocardial damage and severe psychological distress. Little is known of the burden of…”
Get full text

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study by Hendriks, L.E, Derks, J.L, Postmus, P.E, Damhuis, R.A, Houben, R.M.A, Troost, E.G.C, Hochstenbag, M.M, Smit, E.F, Dingemans, A.-M.C

“…Highlights • OS significantly longer in single organ metastatic disease compared to 2 or ⩾3 organs. • Single organ metastases also prognostic in subgroup of18…”
Get full text

Nintedanib for the treatment of symptomatic radiation pneumonitis. A Case Report by Kuipers, M.E., Van Doorn-Wink, K.C.J., Postmus, P.E.

“…Radiation induced pneumonitis is a common side effect of thoracic radiotherapy. We report a case of a patient diagnosed with symptomatic radiation pneumonitis…”
Get full text

NT-proBNP reflects right ventricular structure and function in pulmonary hypertension by Gan, C. T, McCann, G. P, Marcus, J. T, van Wolferen, S. A, Twisk, J. W, Boonstra, A, Postmus, P. E, Vonk-Noordegraaf, A

“…The aim of the current study was to investigate whether alterations in N-terminal pro brain natriuretic peptide (NT-proBNP) reflect changes in right…”
Get full text

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer by Stahel, R., Thatcher, N., Früh, M., Le Péchoux, C., Postmus, P.E., Sorensen, J.B., Felip, E.

“…The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel…”
Get full text